This
site is provided as a public service to anyone interested in researching
Enzo The
intent of this site is not to hype or bad mouth the company but rather offer
links to information, news, articles or comments about Enzo so you can
do your own research faster and easier then sifting through hundreds (sometimes
meaningless and deceptive) posts for pertinent information.
All links,
information and comments should be considered as OPINION of the respective
author - click here for disclaimer.
This
site is FREE for all to access, I make no money off this site or information,
I have no hidden agenda.
This site has grown due to the efforts of
people like yourself who have helped supply the links contained on this
page.
<== Click on Double Helix for
a pretty cool HIV Virus Lifecycle Animation
If you have any information,
links, comments to contribute to this site you can email them to me at
Anthony@grq.net If you find any errors or
bad links please email me with the specific problem.
This site is NOT affiliated
with Enzo or the Yahoo message boards in any way.
You can find the official
Enzo home page at www.enzo.com You can go to the Enzo
message board on Yahoo by clicking here If you are just starting out and want to research Enzo - you might want to start with the links with a star
Click
HERE for Enzo's complaint for breach of contract against
Affymetrix filed 10/28/03.
Links
to ENZO news, related articles and comments: (please note that these links do expire, but will be left up
as a chronological list of events.)
Jan 14, 2004 -
Phase I/II
HIV Gene Therapy Trial Initiated Enzo Biochem Tells Annual Meeting
Dec 24, 2003 -
Enzo Biochem, Inc. Financials
Dec 17, 2003 -
Clarification and Correction: Enzo Biochem Reports Operating
Results for Fiscal 2004 First Quarter
Dec 15, 2003 -
ENZO BIOCHEM INC Files SEC form 10-Q, Quarterly Report
Dec 15, 2003 -
Enzo Biochem Reports Operating Results for Fiscal 2004 First
Quarter
Dec 11, 2003 -
Enzo
Biochem, Inc. Schedules Fiscal 2004 First Quarter Operating Results
Teleconference for Tuesday December 16, 2003, at 8:30 AM E.T.
Nov 6, 2003 - Enzo
Biochem Gene Vector for HIV Cleared to Begin Phase I/II Clinical Trial at New
York Presbyterian Hospital-Weill Medical College of Cornell University
Oct 30, 2003 -
TriPath Imaging in
New Pact With Enzo Biochem Unit
Oct 29, 2003 - ENZO BIOCHEM INC Files SEC
form 10-K, Annual Report
Oct 29, 2003 - Q4 2003 Enzo
Biochem Earnings Release - Before Market Open
Oct 29, 2003 - Enzo Biochem Reports
Operating Results for Fiscal Year Ended July 31, 2003
Oct 29, 2003 - Affymetrix Continues
Supply of Labeling Reagents
Oct 28, 2003 - Enzo Biochem Says Lawsuit
Filed Against Affymetrix for Breach of Agreement
Oct 27, 2003 - Enzo Biochem Develops New
Therapeutic Platforms to Treat Immune-Mediated Diseases
Oct 23, 2003 - Enzo Biochem, Inc.
Schedules Fiscal 2003 Year End Operating Results Teleconference for Wednesday
October 29, 2003
Sept 16, 2003 - Enzo Biochem Reports on Meeting in Israel
Sept 15, 2003 - Enzo Biochem to Present at UBS Global Life Sciences Conference
June 26, 2003 - Enzo
Biochem, Inc. Financials
June 18, 2003 - ENZO
BIOCHEM INC Files SEC form 8-K, Financial Statements and Exhibits
June 16, 2003 -
Enzo Biochem
3rd-Quarter Net 4 Cents/n/ernShare - Dow Jones Business News
June 16, 2003 - Enzo Biochem Reports FDA
Removes Clinical Hold on Company's HIV Gene Therapy Trials - Business Wire
June 16, 2003 - InPlay: Enzo Biochem reports Q3 EPS
- Briefing.com
June 16, 2003 - Q3 2003 Enzo
Biochem Earnings Release - 08:30 am ET - CCBN
June 16, 2003 - Enzo Biochem Announces
Third Quarter and Nine Months Operating Results - Business Wire
May 23, 2003 - [audio] Option Byte: Enzo
Biochem [1.1 min]
May 20, 2003 -
Enzo Biochem
Crohn's Drug Study Yields Positive Results
May 20, 2003 -
Enzo Biochem Reports
Phase I Clinical Trial Results of a New Mode of Crohn's Disease Treatment
March 25, 2003 -
ENZO BIOCHEM INC Financials
March 14, 2003 -
ENZO BIOCHEM INC -
Quarterly Report (SEC form 10-Q)
March 14, 2003 -
Q2 2003 Enzo
Biochem Earnings Release - Before Market Open
March 14, 2003 -
Enzo Biochem Reports
Continuing Growth in Second Quarter Operating Results
March 10, 2003 -
Enzo Biochem Announces
Settlement with Two Companies in Patent Suit
March 10, 2003 -
Fiscal 2003 Second
Quarter Operating Results Teleconference for Friday March 14, 2003, at 8:30 AM
E.T.
December 16, 2002 -
ENZO BIOCHEM INC -
Quarterly Report (SEC form 10-Q)
October 29, 2002 -
ENZO BIOCHEM INC - Annual
Report (SEC form 10-K)
June 14, 2002 -
ENZO BIOCHEM INC - Quarterly
Report (SEC form 10-Q)
March 18, 2002 - Enzo
Biochem Issues Statement Asserting Digene Infringes Enzo Patent
March 18, 2002 - Enzo
Biochem Says Digene Infringes Enzo Patent
March 18, 2002 - Enzo
Biochem Reports Operating Results for Fiscal Second Quarter and Six Months
March 15, 2002 - Digene
Corporation Files Patent Suit Against Enzo Biochem
March 15, 2002 - Enzo
Biochem, Crosswave Communications, Penford, and Actuant Events to be Broadcast
by Vcall over the Internet
March 15, 2002 - Digene
files patent lawsuit against Enzo
March 12, 2002 - Enzo
Biochem, Inc. Schedules Second Quarter 2002 Operating Results Teleconference
For Monday March 18, 2002, At 8:30 AM E.T.
Feb. 27, 2002 - Pre-clinical
Animal Study of Enzo Biochem Immune Regulation Treatment of Liver Cancer
Detailed in January Issue of
'Cancer'
Jan 23, 2002 - Enzo
Biochem Announces 5% Stock Dividend At Annual Meeting
Shareholders Also Hear About
Developments in Phase 1 Trial Of Enzo's Proprietary Gene Medicine for HIV-1
Dec 18, 2001 - Q1
2002 Enzo Biochem Earnings Release - Before Market Open
Dec 17, 2001 - ENZO
BIOCHEM INC (ENZ) Quarterly Report (SEC form 10-Q)
Dec 17, 2001 - Enzo
Biochem Reports Gains in First Quarter Operating Results
Dec 14, 2001 - Ryder
System, Enzo Biochem and Azz Events to be Broadcast by Vcall Over the Internet
Nov. 20, 2001 - Enzo
Biochem Inc Quarterly Income Statement
Nov. 14, 2001 - Enzo
Biochem Says New Pre-Clinical Animal Study of Immune Regulation Medicine
Supports Earlier Findings On Treatment
of
Liver Cancer. Presentation at Liver Conference Indicates Treated Mice
Survived
Nov. 12, 2001 - Enzo
Biochem Announces Plans to Initiate Double-Blind Study of Hepatitis B EHT899
Medicine
Oct. 29, 2001 - Enzo
Biochem Reports Strong Gains in Fourth Quarter and Fiscal 2001 Operating
Results
Oct. 29, 2001 - ENZO
BIOCHEM INC (ENZ) Annual Report (SEC form 10-K)
Oct. 25, 2001 - Enzo
Biochem, Inc. Schedules Fiscal Year 2001 Operating Results Teleconference
for Tuesday October 30, 2001, At 8:30 AM E.T.
Oct. 12, 2001 - Enzo
reports benefits in Phase II for hepatitis drug
Oct.. 12, 2001 - Enzo
Biochem Reports Improvement in Key Indicators Among Subjects in Phase II
Hepatitis B Study
Oct. 5, 2001 - Enzo
Biochem Presentation Friday, October 12, At UBS Warburg Conference to be
Available Via Telephone
Sept. 20, 2001 - Enzo
Biochem Issues Statement
July 12, 2001 - Enzo
Biochem Receives Authorization To Begin Phase 1 Study On Innovative Crohn's
Disease Treatment
July 11, 2001 - WSJ - Enzo
Biochem, Affymetrix Help Drag Down Biotech Index
Excerpt: Enzo Biochem Inc. (ENZ) President Barry Weiner said, at least
for Enzo, there were "no adverse events" causing Wednesday's drop. He attributed
the drop in his company's stock to the weakness and volatility in the sector,
and to "nervous" investors.
June 14, 2001 - Quarterly
Report (SEC form 10-Q)
June 14, 2001 - Enzo
Biochem Reports Strong Gains in Operating Results
June 11, 2001 - Enzo
Biochem, Inc. Third Quarter Teleconference Scheduled for Thursday June
14, 2001, At 8:30 AM
June 8, 2001 - Enzo
Biochem Names Irwin C. Gerson to Its Board of Directors
June 4, 2001 - Enzo
Biochem, in Report to Gene Therapy Society Annual Meeting,
Announces Continued Expression of Anti-HIV Antisense RNA in Clinical Trial
May 28, 2001 - Long Island
Newsday - Picture
Looks Brighter for Biotech Stocks - Enzo Featured
May 24, 2001 - ON24 Enzo
Biochem: Profits and Potential - Audio
- Text
Transcript
May 23, 2001 - Enzo
Biochem Reports On Successful Treatment of Colitis in Preclinical Studies
May 14, 2001 - Enzo
Biochem Awarded Pioneering Patent In U.S. With Wide Application for Nucleic
Acid Diagnostics and Testing
Biotechnology
Stocks With Bright Futures - Courtesy of MarketReporter.com
?,?, 2001 - Results
of Phase I Gene Medicine Trial Released - FREE registration is required.
March 19, 2001 - ENZO
BIOCHEM INC (ENZ) Quarterly Report (SEC form 10-Q)
March 15, 2001 - Enzo
Biochem Reports Strong Second Quarter Operating Results - Revenue Increases
20%, Pre-Tax Income Advances 77.8%
March 13, 2001 - Enzo
Biochem, Inc. to Hold Teleconference On Thursday, March 15, 2001 to Discuss
Second Quarter Results
February 6, 2001 - Medscape
- Enzo
Biochem Reports Early Data on Stem Cell Therapy for HIV
NEW YORK (Reuters Health)
Feb 06 - Enzo Biochem reported on Tuesday that phase I clinical data suggest
autologous stem cell gene therapy may be effective in treating HIV-infected
adults. The company presented the early results for its therapy, HGTV43,
during a session of
the 8th Conference on Retroviruses
and Opportunistic Infections in Chicago. Weiner said that an upcoming phase
II trial, to be conducted in 3 locations, will test for enhanced expression
of CD4+ cells. He added that Enzo Biochem would recruit between two and
20 HIV patients with low T-cell counts at each location. "The results of
this phase I trial are very exciting and very encouraging," said Dr. Marcus
Conant, a principal investigator of the trial at the University of California
at San Francisco. "We may now have the ability to restore the immune systems
of HIV-infected patients."
February 6, 2001 - Audio:
Mining for Gold in February
February 6, 2001 - Gene
therapy approach may work for AIDS
February 6, 2001 - Enzo
Biochem, in Report to Medical Conference,
Says It has Accomplished First Successful Stem Cell Gene Therapy in Adults
January 24, 2000 - Enzo
Biochem Comments On Court Ruling
January 16, 2000 - Enzo
Biochem Announces 5% Stock Dividend At Annual Meeting
January 11, 2000 - LI
Firm Reports Success In Trial of AIDS Treatment - Long Island Newsday
January 11, 2000 - Enzo
Biochem Reports Successful Results of Phase I Clinical Trial of HGTV43
HIV-1 Gene Medicine Product December 14, 2000 - Enzo
Biochem Reports Record First Quarter Operating Results
Pre-Tax Operating Profits Increase by 85%
December 11, 2000 - Enzo
Biochem, Inc. to Report First Quarter 2001 Results and Host Teleconference
On Friday, December 15, 2000
Company Comments On Stock's Activity
November 30, 2000 - Enzo
Biochem Receives Approval for Human Trial for New Medicine to Treat Hepatitis
C and Associated Liver Cancer
Trial to Test New Enzo-Developed Broad Spectrum Antigen Immune Regulation
Product
November 6, 2000 - Enzo
Biochem, Inc. upgraded from Buy to Strong Buy at UBS Warburg
November 6, 2000 - ENZO
BIOCHEM UPPED TO 'STRONG BUY' FROM 'BUY' AT UBS WARBURG
November 2, 2000 - LONG
ISLAND INC. / Enzo Biochem Reports Record Yearly Earnings - Newsday
November 1, 2000 - Enzo
Biochem Inc Reiterated 'Strong Buy' at HCFP/Brenner
October 31, 2000 - Enzo
Biochem Announces Results of Phase I Treatment for HBV Infection
Positive Report On Enzo's Proprietary Medicine EHT899 Presented At Meeting
of Liver Experts
October 30, 2000 - ENZO
BIOCHEM INC (ENZ) Annual Report (SEC form 10-K) - for EDGAR
SEC LINK click
HERE October 30, 2000 - Science
News: Enzo Biochem Says Drug Suppresses Liver Cancer in Mice October 30, 2000 - Enzo
Biochem Reports Researchers Using Its Technology Successfully Suppressed
Human Liver Cancer in Mice
October 11, 2000 - Enzo
Biochem May Be Ready to Boom - Businessweek - INSIDE WALL STREET ONLINE
On the heels of a promising HIV drug trial, more potential lifesaving
therapies are in the works -- and maybe some big partnerships.
October 5, 2000 - Coverage
initiated on Enzo Biochem, Inc. by HCFP/Brenner Sec - STRONG BUY - Briefing.com
October 5, 2000 - HCFP/Brenner
Securities Initiates Coverage of Enzo Biochem, Inc.
October 3, 2000 - Enzo
Inches Forward in HIV Fight ON24
October 2, 2000 - Enzo
Biochem (ENZ) Senior Vice President Dean Engelhardt on the company's fight
against HIV
October 2, 2000 - Patient
makes anti-HIV immunity cells in Enzo trail October 2, 2000 - Enzo
Biochem Reports New Data On Phase I HIV Test Shows Engraftment of Engineered
Cells in Bone Marrow September 12, 2000 - Coverage
initiated on Enzo Biochem, Inc. by UBS Warburg - Briefing.com
September 12, 2000 - Enzo
Biochem on CNBC - 09/12 12:30P (DJ) DJ O'BRIEN AND BAUMAN'S HOT STOCKS
September 12, 2000 - Enzo
Biochem Inc Rated New 'Buy' at UBS Warburg Source: Bloomberg News
September 12, 2000 - Coverage
Initiated II ENZ- UBS Warburg- Buy- $76
September, 7, 2000 - Stay
Tuned! More to Come - by James Baker
August 29, 2000 - ISE
to list options Aug. 30
August 7, 2000 - Japanese
Patent Office Upholds Enzo Biochem Patent Covering Technology for Genetic
Analysis
July 25, 2000 - Enzo
Biochem Announces New Patent Allowances in Both the U.S. and Canada
July 10, 2000 - StreetsideInvestor.com
- It Makes Sense, Anti-sense
June 23, 2000 - Interview
with BARRY WEINER on biznews1.com
June 20, 2000 - [audio]
ON24/StreetAdvisor.com: Enzo's Fuel? Glaxo Deal Rumors
Click HERE to view the TRANSCRIPT
of the above Audio.
June 16, 2000 - [audio]
ON24/StreetAdvisor.com: Enzo, the Biotech Elder [1.6 min] - ON24
Great audio clip and stated that they
INITIATED
COVERAGE with a HOLD rating!
Click HERE to view the TRANSCRIPT
of the above Audio.
June 15, 2000 - Enzo
Biochem Reports Increased Third Quarter Operating Results
June 14, 2000 - after the
bell - ENZO BIOCHEM INC
- Quarterly Report (SEC form 10-Q)
June 14, 2000 - Enzo
Biochem Commences Phase II Trial of Treatment for Chronic Hepatitis B
June 2, 2000 - [audio]
ON24/Briefing.com: Spotlight: Enzo Biochem [2.3 min]
June 2, 2000 - Enzo
Biochem Says Data Shows Significant Progress in Human HIV Gene Medicine
Trial May 23, 2000 - Enzo
Biochem Treatment Could Alleviate Crucial Debilitating Side Effects of
Bone Marrow Transplantation
April 27, 2000 - Gene
Therapy Gets New Life - Great Gene Therapy Success Article!
April 20, 2000 - Axxel
Knutson archived radio interview about Enzo
April 17, 2000 - Enzo
Biochem Inc Reinstated as "Strong Buy" by First Allied Securities
April 13, 2000 - Enzo
Biochem says stock move mirrors sector
April 13, 2000 - Enzo
Biochem Says Outlook Remains Highly Favorable for Company's Growth
April 9, 2000 - Newsweek
-The
Gold Rush
April 4, 2000 - Enzo
Biochem Second Quarter Report to Shareholders Fiscal 2000 (definitely
worth reading.) April 4, 2000 - The
Pressure Is On / Gene thearpy researchers are persisting amid slow progress
and stricter monitoring
(Long Island Newsday - Enzo not mentioned but good article for them.)
April 3, 2000 - INDUSTRY
FOCUS section of Newsday (Enzo 1/2 way down page)
Mar 29, 2000 - A
Harmless Virus Shows Promise, May Revive Hopes for Gene Therapy
(Enzo not mentioned but they should have been.)
Mar 28, 2000 - Enzo
Biochem Reports Successful Preliminary Results From Phase 1 Clinical Trial
for Treatment of Hepatitis B Patients Mar 16, 2000 - Enzo
Biochem Reports Record Second Quarter Operating Results
Mar 15, 2000 - Enzo
Biochem Awarded Patent Covering Method to Correct Certain Gene Abnormalities
Mar 02, 2000 - Hemophilia
gene therapy seen better than expected - Non-Enzo related but a great article(s)
on how gene therapy can be a success - with only 3 patients in the study! Click
here for Reuters release - Click
here for The Associated Press release
Feb 24, 2000 - Enzo
Biochem Announces Introduction of Universal Kits for Genomic Analysis
Feb 20, 2000 - AIDS
Study Raises Hopes for Gene Therapy Treatment
Enzo not mentioned but a good article for antisense treatment - see Larry
Glaser's comments below
Feb.
18, 2000 WSJ Articleexcerpts - Online
Investors Feel Good About Enzo's New Treatment Feb. 17, 2000 - Article
about Enzo in "Blood Weekly" Newsletter - "Survival
of Genetically Engineered Blood Cells in HIV-1 Human Study Reported.
Feb.
16, 2000 CNBC Coverage -STOCKS
ANALYSIS
Feb.
16, 2000 Dow Jones Article - excerpts - Enzo
Biochem Encouraged by HIV Gene-Therapy Trial Data Feb.
9, 2000 Long Island Newsday - excerpts
-
Newest
Apples of Wall Street's Eye Enzo and other biotechs now hot with investors Feb.
4, 2000 Long Island Newsday article excerpts - LI
Firms Show Promise In AIDS Treatment Field.
Search for news
on ENZO: Dow Jones Search - Click
here New York Times Search
- Click
here Business Week Articles
- Click
here Long Island Newsday Search Current/Past
Editions (search for "Enzo Biochem") - Click
here Yahoo Latest news
releases - Click here Datek Lastest news
releases -
Click
here AIDSmap.com news - Click
here TRANSCRIPTS (CNBC, CNNfn, etc) and Articles
for Symbol ENZ - Click
here
Conferences/presentations:
Internet
Conference Reports in2002
9th
Conference on Retroviruses and Opportunistic Infections
53rd
American Association for the Study of Liver Diseases (AASLD) annual Meeting
and Postgraduate Course November 1-5, 2002, Boston MA
Conference web site: http://aasld.org/
6th
International Congress on Drug Therapy in HIV Infection
Glasgow, Scotland November 17 - 21, 2002
Conference web site:http://www.ias.se
National Institutes of Health - Video Cast of Past Events/Conferences
(great link!) - click
here
Interesting Video Cast from above site: Recombinant DNA Advisory Committee
(RAC) Thursday, March 08, 2001 Enzo Biochem presenting - click
here. Note: at about 45 minutes into the above
recording are Dr. Markert's comments, one of which is to compliment the Enzo group of scientists. RAC Dr. M.'s exact quote is: "This is a
very fabulous investigator team". Please listen to the ENTIRE recording
regarding Enzo to get the complete picture of what transpired.
GDVMarch's - Another Perspective:
Failure or Success? - click here
1999?? Barry Weiner presentation - Barry discussing Enzo Biochem and
its plans. - click here (Windows media player presentation - 9MB file - long download). If
the file does not open when you click on the link, try the following: Save
it to your hard drive by RIGHT-CLICKing on the link above and choose "save
as" or "save link as" and remember the path to where you saved it. After
the file "enzo1999.asf" downloads, open Windows Explorer and go to the
path that the file was downloaded to and double click on it. If this
does not work, email me at Anthony@grq.net and I will email it to you.
I do not know the date that this presentation or who it was to or even
if this is the complete presentation. I was told by the poster who
emailed it to me that it was mid-1999. If anyone has knowledge to
the date or details of this presentation, email them to me and I will add
it here. Also if anyone has a text transcript of this presentation,
that would also be greatly appreciated.
GDVMARCH's Alternate Perspective on Contents of above video. - click
here
Minutes of the Recombinant DNA Advisory Committee Meeting on March 8,
2001 - click here (in Acrobat Reader PDF format - click here
to download Acrobat Reader now.)
The Fourth Annual
Meeting of the American Society of Gene Therapy,
May 30-June 3, 2001,
Seattle, Washington. Click HERE
for ENZO abstract.
8th Conference
on Retroviruses and Opportunistic Infections(February 4-8, 2001,
Chicago,
IL)· Digestive Disease Week 2001(May 20-23, Atlanta, GE);
5th International
Workshop on HIV Drug Resistance and Treatment Strategies(June 5-9,
2001, Scottsdale,
AZ);
1st International
IAS Conference on HIV Pathogenesis and Treatment(July 8-11, 2001,
Buenos Aires,
Argentina);
International
HIV Workshop on Management of Treatment-Experienced Patients
(September
19-21, 2001, Chicago IL);
41st Interscience
Conference on Antimicrobial Agents and Chemotherapy
(ICAAC)(September
22-25, 2001, Chicago, IL);
6th International
Congress on Drug Therapy in HIV Infection(October 5-10, 2001,
Melbourne,
Australia);
3rd International
Workshop on Adverse Drug Reactions and Lipodystrophy in HIV(October
23-25, 2001,
Athens, Greece);
39th Annual
Meeting of the Infectious Diseases Society of America (IDSA)(October
25-28, 2001,
San Francisco, CA);
52nd Annual
Meeting of the American Association for the Study of Liver
Diseases
(November 9-13, 2001, Dallas, TX). Conference Home Page Link:
http://www.aasld.org GDVMARCH's
AASLD Abstracts 2001- Explanation re: Group 1, Phase II, Hep-B. (l0/l0/01)
- click HERE
American Association for Study of Liver
Disease annual conference, October 27-31, 2000, Dallas, Texas. Enzo Biochem
presentations click HERE. Conference Home
Page Link: http://www.aasld.org
Enzos abstract for The Third Annual Meeting
of the American Society of Gene Therapy Conference - May 31 - June 4, 2000
Denver, Colorado - Program No.: 379. In Vivo Maturation of U1/Anti-HIV-1
Antisense RNA-expressing CD4+ Cells from Transduced CD34+ PBSC in HIV-1
Seropositive Individuals.
http://www.academicpress.com/www/journal/asgt/8624.html
Informative and
Notable Posts: (All
links, information and comments should be considered as OPINION
of the respective author)
Enzo's January 2000 TO January 2004 Press Release Statements on HGTV-43: A
Word-for-Word Compilation by GDVMARCH- click here
GDVMARCH's Notes from Enzo ASM 1-14-04 -
click here
GDVMARCH's Notes from the Enzo-UBS 2002 Warburg Conference
- click here
Oct. 21, 2002 - GDVMARCH's Notes from the Enzo-UBS 2002 Warburg Conference
- click here
Oct. 15, 2001 - Gdvmarch Thoughts On UBS-ENZO 10/12/01 Conference.
Pt.1-4 - click here
Sep. 18, 2001 - A MANHATTAN REPORT OF SORTS by GDVMarch - click
here
Nov. 30, 2000 - Larry Glaser - Pertinent posts
copied from his closed ENZO Appreciation Board - click
here
Nov. 15, 2000 - Pricing An Option Determining "Fair Value", contributed
by hippocratesfatherofmedicine - click here
Nov. 15, 2000 - "After A While You Learn", contributed by whoisajohngalt
- click here
Oct. 15, 2000 - Larry Glaser's Interpretation/opinion of the Brenner
Report - click here
Oct. 2, 2000 - Larry Glaser's Notes from the Enzo-UBS Warburg Conference
- click here
Oct. 2, 2000 - GDVMARCH's Notes from the Enzo-UBS Warburg Conference
- click here
July 2, 2000 - GDVMarch "long, but great
post" - click here
May 9, 2000 - "It's the science, stupid!"
- by: Smithlink - great post - click here
Larry
Glaser's Heck it Works Paper Larry's Paper - Click
here Articles - Click
here
Mar 16, 2000 - Larry Glaser's Comments
on Enzo Gene Repair Press Release - click here.
Feb 22, 2000 - Larry Glaser's "Response
to the Thrash of Enzo by Jim McCamant on CNBC"
Feb 20, 2000 - Larry Glaser's Comments/Response
to "AIDS Study Raises Hopes for Gene Therapy Treatment" Article - News
out about success with HIV using Genetic Antisense against TAT
Feb. 18, 2000 Larry
Glaser's Letter to the WSJ Reporter - Aaron Elstein - click
here (This is the place to start to find out about what Enzo has done.)
Very informative post from ICPOSSE2000
on the science behind a HIV-1 human study - click
here ICPOSSE2000's
excellent dissertation on viral loads - "Viral Load is NOT
a useful measurement of whether Enzo’s strategy is working" - Click
here to read more.
Another source for ICPOSSE2000's posts
=> HIV.html
Larry Glaser's unedited ASM notes => EnzoASM.html
Links
to ENZO Research Reports,
Coverage, Recommendations, Opinions, etc. :
BRENNER
REPORT April 2, 2001
Click HERE for
the report in Acrobat Reader PDF Format Click HERE if
you don't have Acrobat Reader
I was told that Brenner did not object to the posting
of this report since it is already in the public domain.
If you need more information
please call them at (212) 707-0327 or email them for more information
at sgerszonowicz@hcfpbrenner.com or visit their website at:
http://www.brennersecurities.com
Click HERE for a downloadable
Word Format right click the above Word Format
link and choose Save Link As and save it to your hard
drive.
I was told by the Managing Director at Brenner that they
would not object to me posting this report since it is already in the public
domain.
They were very nice about this
so if you need more information please call them at (212) 707-0327
or email them for more information at sgerszonowicz@hcfpbrenner.com or visit their website at:
http://www.brennersecurities.com
Wright Investors' Service => click
here
Analyst History => click
here April 17, 2000 - Enzo Biochem Inc Reinstated
`Strong Buy' at First Allied => click
here
The TomorrowCast Trading System's (Enzo
mentioned several times on the page) => click
here
Newsday Top 100 Companies on Long Island
(includes Enzo - 06/04/2001) => click
here
Newsday Top 100 Companies on Long Island
(includes Enzo - 06/05/2000) => click
here
Newsday Top 100 Companies on Long Island
by NET INCOME (includes Enzo - from 6/99) => click
here
Links
to the Enzo Clubs and message boards: http://www.clubs.yahoo.com/clubs/enzoappreciation
- Board closed by Larry 12/11/2000.
Contained Information about everything
you ever wanted to know about Enzo - thanks to Larry Glaser's (aka VANGO888
and enzo_mutant) research and hard work. Prior
to the board closing and with Larry's permission, several
pertinent
posts had been copied to the Unofficial Enzo Home Page and placed HERE.
If you have a problem keeping up with the
acronyms being used like - IMO, IMHO, etc. look it up:
For an index of Acronym's used in Chat
rooms and Message boards => click
here
All
About Stock Bashers and Hypsters - How Stocks Get Manipulated and Why -
ALL
SHOULD READ:
New York Times Article: Incognito
Spinmeisters Battle On-Line Critics: When a Company's Product Is Under
Fire, One Option is to Plant a Defender in the Chat Room. - click
here
Ways of a Market Maker, Pump & Dump vs
Short & Distort, Normal vs Shorted bid/Ask, Shorts on Message Boards,
Boiler-Net Rooms and the Internet, All that is Short, Convertible Debentures
& Stock Prices - GREAT RESOURCE - MUST
READ - click
here
ANATOMY OF A BASHER
-
BASHERS
NEVER Bash A BAD STOCK. A must read for anyone who reads message
boards => click here
CNBC REPORT: Don't
Get Burned by Message Boards "There's been a migration
of fraudulent behavior onto the Web because it's faster, easier and cheaper
than a boiler room"
MYTH - "Market
Makers Can Short All They Want" - click
here
Doctor Wins Net
Libel Verdict Judge Calls Anonymous
Internet Message ‘Despicable’ -
click
here Dr.
Sam D. Graham Jr. won a $675,000 judgment against another doctor
ho
published false information about him on an Internet bulletin board
NY Times Aliases
Subject of Internet Libel Case NYTimes
CYBER LAW JOURNAL -
click
here
*Procedure to cut and paste information
to a form or email:
Highlight the text you want to copy and hit
CTRL-C
(Ctrl key and C) on your keyboard.
Open the form or Email message
screen and paste it by hitting
CTRL-V (Ctrl key and V).
Quotes,
Charts, SEC Filings, Insider Trading, etc.
CURRENT SHORT INTEREST => click
here
For Delayed Live Charts from Quote.com
for ENZO click here => Quote.com
Performance Information on Enzo - charts,
short interest => click
here
For the Latest SEC Filings for Enzo click
here => EDGAR
OnLine
For Insider Trading on Enzo => click
here
CNNfn Information on Enzo => click
here
Today's Last 10 Trades on Enzo => click
here
Trade volume for Enzo Stock (Large Blocks,
%Institutional)
Click on linke then enter the symbol ENZ
and click go => Thomson
I-Watch
All outstanding Options and LEAPS for ENZO
click here =>
www.cboe.com
Barchart.com - opinion rating on Enzo =>
click
here
Technical Indicator Charts => click
here
To see Institutional Ownership in Enzo
=> click
here
Another site for Institutional Holdings
by Institution => click
here
FREE
Level II quotes (delayed) for two months from the following site - www.stocktoys.com This site has other neat
toys also. The level 2 shows you how many people are on the bid and how
many are on the ask which can really give you an understanding of how strong
a current price is and when the best time is to buy or sell. This is what
your broker uses.
Sites
that contain Enzo Patents:
JULY 12, 2001: RABBANI, ELAZAR - NOVEL PROPERTY EFFECTING AND/OR PROPERTY
EXHIBITING COMPOSITIONS FOR THERAPEUTIC AND DIAGNOSTIC USES => click
here
JULY 5, 2001: SOLID CHIMERIC ORGANS, ANIMAL MODELS HAVING SAME, PROCESS
FOR PREPARING SAME, NON-TUMORIGENIC IMMORTALIZED HUMAN CELL LINES, SUSCEPTIBLE
CELLS AND CYTOPATHIC MAMMALIAN VIRUSES => click
here
MARCH 29, 2001: Novel process, construct and conjugate for producing
multiple nucleic acid copies => click
here
Search the US Patent & Trademark Office
=> click
here
ENZO
Related Contact Information and Phone Numbers:
Enzo Biochem, Inc. Corporate Offices
527 Madison Ave
New York, NY 10022
Phone: 212-583-0100
Fax: 212-583-0150
info@corp.enzobio.com
Enzo HQ (Barry, David) - 212-583-0100
HY Gross - 212-583-0100 Enzo investor
relations
Steve Anreder - 212-532-3232 Enzo
PR person
Dick Keating - 206-780-9458 Enzo
outside shareholder relations in Seattle Washington.
Clinical Trial Databases & Info.
http://clinicaltrials.gov/-
Clinical Trials for Experimental Treatments http://www.centerwatch.com/main.htm
- CenterWatch Clinical Trials Listing Service http://www.wiley.co.uk/genetherapy/clinical/
- Gene Therapy Clinical Trials
U.S. Food and Drug Administration Congressional Testimony - click
here (The site includes recent Congressional testimony that discusses in
depth issues such as,
compassionate use, accelerated use, expanded access, fast-track and
other processes by
which, under certain circumstances, the availability of investigational
drugs, therapies and
biologics can be expedited, etc.)
Mid-2003 annual report of the UCSF trial (#230) -
click here
Sample Enzo consent form for the trial at Cornell
(#443) - click here
The above consent form is the original
version, dated 1/2001, as considered by the RAC, NOT the one potential trial
participants now would be reading and considering.
Information
and articles about Gene Therapy
What is Gene Therapy? => click
here
Pushing DNA into cells makes a safe form
of gene therapy work => click
here
Gene Therapy May Heal Some Injuries =>
click
here
Disclaimer The intent of this page is to provide
links to information, news articles, informative posts, etc. All links,
information and comments should be considered as OPINION of the respective
author. No one should buy, sell, hold, or make any other investment decision
on the basis of message board posts, links or opinions. Such information
is useful as guides to further inquiry and often contain pointers to documentation
or resources, but are never to be taken, used, or relied upon as investment
advice.
If you feel that any of these links violate
any copyright laws, please email me at Anthony@grq.net
so
that I can correct or remove the link.
Thank you to all that have contributed
to this site and helped make this resource available to the general public.
Information Collected and Stored Automatically This site DOES NOT use cookies
(a cookie is a small data file that can be stored on disk or resides in
the memory of your computer and contains information about you that is
pertinent to a Web site). It does however maintain a server log like
most other sites. If you do nothing during your visit but browse through
the website, read pages, or download information, the server gathers and
stores certain information about your visit automatically. This information
does not identify you personally. It automatically collects and stores
only the following information about your visit:
1.The Internet domain (for example, "xcompany.com" if you use a private
Internet access account, or "yourschool.edu" if you connect from a university's
domain) and IP address (an IP address is a number that is automatically
assigned to your computer whenever you are surfing the Web) from
which you access our website;
2.The type of browser, operating
system and screen resolution used to access this site;
3.The date and time you
access this site;
4.The pages you visit;
and
5.If you linked to this
website from another website, the address of that website.
This information is used
to help us make our site more useful to visitors -- to learn about the
number of visitors to our site and the types of technology our visitors
use. We do not track or record information about individuals and their
visits.